obesity-995x60.png
FEATURED ARTICLES
Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs
Cognixion CTO Chris Ulrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
![GettyImages-2152658176 oncology, doctor, patient]( "How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?")
How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.
-
![Doctors board room meeting-GettyImages-1365555907]( "Highlights From The 2025 International Hepatitis B Meeting")
Highlights From The 2025 International Hepatitis B MeetingFor biotech and pharmaceutical teams, the core message was clear: progress is accelerating, but success still depends on smart study design, fit-for-purpose endpoints, and operational execution.
-
![Boardroom collaboration, healthcare, hospital manager-GettyImages-2203581622]( "How CROs, Sites, PIs, And Sponsors Work Better Together")
How CROs, Sites, PIs, And Sponsors Work Better TogetherEach role is critical, yet operating in isolation results in slower timelines, duplicated effort, and missed opportunities. When collaboration replaces coordination, trials gain speed, quality, and patient trust.
SERVICES AND PRODUCTS
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.
Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody targeting with potent payloads to improve patient outcomes.
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
Altasciences’ experienced team specializes in early-phase renal and hepatic impairment studies, delivering tailored clinical pharmacology trials that support your regulatory submissions.
Catalyst Oncology accelerates innovation by aligning strategic insight, deep expertise, and flawless execution. With global reach, we fast-track development timelines through a seamlessly integrated approach, empowering biotechs to deliver life-changing therapies to patients worldwide—faster, smarter, and with purpose.